Cutting Edge Spine launched the EVOLha-DLIF direct lateral interbody fusion system on Jan. 9 following FDA 510(k) clearance.
Three insights:
1. EVOLha-DLIF is designed with PEEK-OPTIMA hyaluronic acid-enhanced material from Invibio Biomaterial Solutions.
2. The company's spine implants featuring the new material have shown early onset bone formation and apposition to its implants.
3. Cutting Edge Spine has seven 510(k) cleared devices and aims to launch several more this year.